Regeneus Ltd. (AU:CMB)
ASX:CMB
Australian Market
Holding AU:CMB?
Track your performance easily

Regeneus Ltd. (CMB) Share Price & Analysis

1 Followers

CMB Stock Chart & Stats


Financials

Annual

CMB FAQ

What was Regeneus Ltd.’s price range in the past 12 months?
Regeneus Ltd. lowest share price was AU$0.30 and its highest was AU$1.60 in the past 12 months.
    What is Regeneus Ltd.’s market cap?
    Currently, no data Available
    When is Regeneus Ltd.’s upcoming earnings report date?
    Regeneus Ltd.’s upcoming earnings report date is Feb 27, 2025 which is in 114 days.
      How were Regeneus Ltd.’s earnings last quarter?
      Regeneus Ltd. released its earnings results on Aug 30, 2024. The company reported -AU$0.177 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.177.
        Is Regeneus Ltd. overvalued?
        According to Wall Street analysts Regeneus Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Regeneus Ltd. pay dividends?
          Regeneus Ltd. does not currently pay dividends.
          What is Regeneus Ltd.’s EPS estimate?
          Regeneus Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Regeneus Ltd. have?
          Regeneus Ltd. has 11,931,006 shares outstanding.
            What happened to Regeneus Ltd.’s price movement after its last earnings report?
            Regeneus Ltd. reported an EPS of -AU$0.177 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Regeneus Ltd.?
              Currently, no hedge funds are holding shares in AU:CMB
              ---

              Regeneus Ltd. Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Fundamentals

              Return on Equity
              -469.28%
              Trailing 12-Months
              Asset Growth
              690.69%
              Trailing 12-Months

              Company Description

              Regeneus Ltd.

              Regeneus Ltd clinical-stage regenerative medicine company. It mainly develops a portfolio of cell-based therapies to address significant unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology diseases. The company uses stem cell and immuno-oncology technologies to develop cell-based therapies. Its product pipeline consists of two platform technologies, Progenza and Sygenus, across three target therapeutic areas namely osteoarthritis, neuropathic pain, and skin wound healing.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              PYC Therapeutics Limited
              Race Oncology Ltd.
              Botanix Pharmaceuticals Limited
              Cryosite Limited
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis